Mylagia
9 Mar 2016
Kidney cancer news
23 Apr 2024
Sick pay - cancer patients are counting the cost
22 Apr 2024
Lenvatinib plus everolimus for patients with metastatic kidney cancer
22 Apr 2024
Adjuvant pembrolizumab prolongs overall survival for kidney cancer patients
17 Apr 2024
Cancer52 manifesto launch
12 Apr 2024
Immunotherapy combinations versus TKIs for papillary renal cell carcinoma
9 Apr 2024
CAR T cell immunotherapy shows promise for patients with kidney cancer
9 Apr 2024
Real world data on the use of cabozantinib plus immunotherapy in the second line
25 Mar 2024
How to manage anxiety and depression when you have kidney cancer
12 Mar 2024
Immunotherapy improves survival in kidney cancer patients with brain metastases
8 Mar 2024
Radiotherapy for the management of renal medullary carcinoma
8 Mar 2024
Manchester patient focus group
8 Mar 2024
NICE approves cabozantinib plus nivolumab for advanced kidney cancer
Most used tags
renal cell carcinoma immunotherapy combination therapy checkpoint inhibitors Cancer nivolumab TKIs overall survival Opdivo sunitinib Sutent cabozantinib progression-free survival NHS England biomarkers ipilimumab Cabometyx pembrolizumab COVID-19 axitinib cancer survival non-clear cell kidney cancer VEGF inhibitors kidney cancer Inlyta coronavirus Yervoy risk factors Keytruda adjuvant therapy metastases targeted therapy papillary RCC everolimus biological markers Afinitor cancer outcomes ASCO first-line treatment NICEArchives
- 2024: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2023: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2022: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2021: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2020: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2019: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2018: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2017: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2016: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
